Prime Medicine Appoints Allan Reine, M.D. As CEO
05/19/25, 7:25 PM
Location
cambridgeIndustry
biotechnology
Prime Medicine has appointed Chief Financial Officer Allan Reine, M.D. as the new CEO following the resignation of Keith Gottesdiener, M.D. The appointment comes amid the company's decision to shelve its clinical-stage genetic medicine and lay off a number of staff.
Company Info
Location
cambridge, massachusetts, united states
Additional Info
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.